TRAW

ONCONOVA THERAPEUTICS INC

TRAW·68232V801·UQ·Common Stock·Healthcare - Biotechnology

TRAW (ONCONOVA THERAPEUTICS INC) is held by 20 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($615,609), VANGUARD CAPITAL MANAGEMENT LLC ($278,231), JANE STREET GROUP, LLC ($182,158). Net institutional sentiment: Mixed.

20
Holders
(2 Elite)
$1.5M
Total Value
63% (19)
Consensus
12 buying - 7 selling
13F: Insider & Congress: Updated regularly
TRAW

Smart Money Verdict

View all
Loading verdict
Held by 20 funds
2 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Apr 28, 2026 · Activists none · Congress none

InsiderOLORBIMED ADVISORS LLCBuy $998KApr 16, 2026
InsiderPNParker Charles NolanVest 15K shDec 12, 2025
InsiderSTShoemaker Mary TeresaVest 6K shDec 12, 2025
Checking access…

Top Holders

Checking access…
Action
Unchanged
730,000$615,6090.0%-75.03%
0
Increased
330,049(+498.0%)$278,2310.0%-56.95%
26
Increased
216,006(+916.9%)$182,1580.0%-54.33%
25
New
164,376$138,6180.0%-50.00%
31
Increased
111,365(+44.4%)$93,9150.0%-84.42%
20
New
91,220$76,0000.0%-50.00%
29
Increased
54,511(+71.4%)$45,9530.0%-68.00%
21
New
37,454$31,5850.0%-50.00%
30
Unchanged
25,802$21,7590.0%-61.47%
0
New
18,092$15,2570.0%-50.00%
25
New
12,579$11,0000.0%-50.00%
24
Decreased
9,941(-0.1%)$8,3830.0%-95.01%
0
New
4,676$3,9430.0%-50.00%
22
Decreased
3,451(-14.8%)$2,9090.0%-61.51%
0
New
1,947$1,6420.0%-50.00%
17
New
500$4140.0%-50.00%
17
Decreased
468(-87.5%)$3950.0%-77.05%
0
Unchanged
262$2210.0%-74.55%
0
Decreased
2(-91.3%)$20.0%-75.51%
0
Unchanged
2$20.0%-74.55%
0

Showing 1-20 of 23

1 / 2
TRAWTRAWONCONOVA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used